ClinicalTrials.gg
RecruitingNCT06953440Updated May 1, 2025

The Effect of Dexamethasone Submucosal Injection After Surgical Extraction of Lower Impacted Third Molars on Trismus and Edema

A Phase 4 interventional study of Dexamethasone Sodium Phosphate Injection and Normal Saline (Placebo) in Swelling/ Edema and Trismus, sponsored by King Abdulaziz University. Recruiting at 1 site in Saudi Arabia. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-05-01.

Sponsored by King Abdulaziz University · Phase 4, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Feb 2024, registered Feb 2025).
  • Started Feb 2024; still recruiting 2 years 9 months later.
Phase
Phase 4
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This clinical trial aims to investigate whether dexamethasone decreases edema and trismus in adults undergoing lower third molar surgical extraction.

The main question it aims to answer is:

Does dexamethasone submucosal injection have a positive impact on trismus and edema after third molar surgery compared to conventional postoperative prescription?

Participants will:

  • Be administered with dexamethasone submucosal injection or a placebo after the surgery.
  • Visit the clinic three times the week after the extraction for follow-up.
Read the detailed description

Patients will be randomly allocated to the test group or the control group by an allocation sequence that is done by the statistician.

To ensure that the patient and OMFS resident are blinded in this study, the corticosteroid and placebo injections are of the same color and size, are stored in similar bottles, and are coded as drug 1 or drug 2. Additionally, they will be placed in sealed envelopes by a dental assistant.

The OMFS resident will withdraw an envelope randomly. The number is recorded in the patient file. Then, the drug will be administered in the buccal vestibule next to the site of extraction after surgery. Thus, the patient, surgeon, and the person responsible for the assessments of swelling and trismus are masked to the type of medication used during each surgical procedure. The drugs used in the different surgeries are only revealed after the acquisition and analysis of all data. Baseline and follow-up measurements will be measured by a standardized ruler. At the first visit, interincisal distance will be recorded to measure trismus. Distance from the angle of the mandible to the outer canthus of the eye, distance from the tragus of the ear to the corner of the mouth, and distance from the tragus of the ear to soft tissue pogonion will be recorded and their mean will be calculated to measure edema. Pell and Gregory classification of the tooth and impaction angulation will be recorded. Facial symmetry and whether the angle of the mandible is palpable or not will be recorded as well. The number of drug that was given to the patient will be recorded.

At the 2nd, 4th, and 7th visits, interincisal distance will be recorded to measure trismus. Distance from the angle of the mandible to the outer canthus of the eye, distance from the tragus of the ear to the corner of the mouth, and distance from the tragus of the ear to soft tissue pogonion will be recorded to measure edema. Facial symmetry and whether the angle of the mandible is palpable or not will be recorded. Whether the patient is able to interact socially or not. If not, was it due to edema, feeling sick, or bad mood. The patient's ability to work, the patient\'s ability to eat the food he is used to eating, and the presence of sleep impairment will be recorded as well.

Surgery will be done by calibrated OMFS residents. After the surgery, the surgeon will use the preassigned randomly picked envelope and administer it in the buccal vestibule next to the surgical site. Patients will be followed up in the 2nd, 4th, and 7th postoperative days.

02

Conditions studied

  • Swelling/ Edema
  • Trismus

Browse trials for

Keywords

  • Extraction
  • third molar
  • wisdom teeth
  • dexamethasone
  • steroids
  • submucosal
03

In context

Edema

566 studies on the registry are indexed under Edema; 95 are open to participants now.

This study's planned enrollment of 66 is above the median of 52 across 401 interventional studies indexed under Edema.

Browse Edema studies →

Lead sponsor

King Abdulaziz University is the lead sponsor of 98 studies on the registry; 19 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with impacted lower third molars requiring surgical extraction.
  • Adults over the age of 18 years old.
  • American Society of Anaesthesiologists (ASA) 1, and ASA 2

Exclusion criteria

Exclusion Criteria:

  • Patients with preoperative intraoral or extraoral swelling.
  • Patients requiring simple extraction (Class I group A according to Pell and ---Gregory classification).
  • Patients with uncontrolled systemic disease such as uncontrolled diabetic - patients.
  • Patients who are allergic to .
  • Patients who are to use corticosteroids such as uncontrolled diabetic patients, and osteoporotic patients.
  • Patients who require extraction of additional teeth at the same visit.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Dexamethasone Group

    Patient received 4 milligrams of dexamethasone

    Drug: Dexamethasone Sodium Phosphate Injection

  • Placebo comparator
    Control Group

    Patient received 4 milligrams of normal saline solution

    Other: Normal Saline (Placebo)

Interventions

  • Patients will receive 4 milligrams of dexamethasone submucosal injection next to the extraction site.

  • OtherNormal Saline (Placebo)

    Patients will receive 4 milligrams of normal saline solution next to the extraction site.

06

What researchers measure

Primary outcomes

  1. Trismus and Swelling

    Baseline and follow-up measurements will be measured by a standardized ruler. At the first visit, interincisal distance will be recorded in millimeters to measure trismus. Distance from the angle of the mandible to the outer canthus of the eye, distance from the tragus of the ear to the corner of the mouth, and distance from the tragus of the ear to soft tissue pogonion will be recorded in millimeters and their mean will be calculated to measure edema. Pell and Gregory classification of the tooth and impaction angulation will be recorded. Facial symmetry and whether the angle of the mandible is palpable or not will be recorded as well. At the 2nd, 4th, and 7th visits, interincisal distance will be recorded in millimeters to measure trismus. Distance from the angle of the mandible to the outer canthus of the eye, distance from the tragus of the ear to the corner of the mouth, and distance from the tragus of the ear to soft tissue pogonion will be recorded in millimeters

    Time frame: From the day of extraction, the 2nd day of surgery, 4th day, and 7th day of surgery.

Secondary outcomes

  1. Social Interaction

    Whether the patient is able to interact socially or not, if not, was it due to edema, feeling sick, or bad mood. The patient will be asked a yes or no question, and their answer will be recorded.

    Time frame: Patients will be followed up in the 2nd, 4th, and 7th postoperative days.

  2. Work Ability

    Whether the patient is able to work on his job or perform daily chores. The patient will be asked a yes or no question, and their answer will be recorded.

    Time frame: Patients will be followed up in the 2nd, 4th, and 7th postoperative days.

  3. Eating Ability

    Whether the patient can eat the food he is used to. The patient will be asked a yes or no question, and their answer will be recorded.

    Time frame: Patients will be followed up in the 2nd, 4th, and 7th postoperative days.

  4. Sleep Impairment

    Whether the patient is able to sleep without impairment. The patient will be asked a yes or no question, and their answer will be recorded.

    Time frame: Patients will be followed up in the 2nd, 4th, and 7th postoperative days.

07

Study locations

1 of 1 sites recruiting
  • King Abdulaziz University, Faculty of Dentistry
    Jeddah, Makkah, Saudi Arabia
    Recruiting
    • Lojain Bassyoni, BDS, MSc, FRCDC · Contactlbassyoni@kau.edu.sa · 00966504623553
    • Lujain Bassyoni, BDS, MS, FRCDC · Principal investigator
    • Razan Baabdullah, BDS, MS, FRCDC · Principal investigator
    • Mohammed Bajunaid, BDS · Sub investigator
    • Badr Alharthi, BDS · Sub investigator
08

References and documents

Publications

  • Hou C, Liu F, Liu C. Comparison of Submucosal With Intramuscular or Intravenous Administration of Dexamethasone for Third Molar Surgeries: A Systematic Review and Meta-Analysis. Front Surg. 2021 Aug 10;8:714950. doi: 10.3389/fsurg.2021.714950. eCollection 2021. PubMed 34447785 ↗
  • Grossi GB, Maiorana C, Garramone RA, Borgonovo A, Beretta M, Farronato D, Santoro F. Effect of submucosal injection of dexamethasone on postoperative discomfort after third molar surgery: a prospective study. J Oral Maxillofac Surg. 2007 Nov;65(11):2218-26. doi: 10.1016/j.joms.2006.11.036. PubMed 17954317 ↗
  • Wanithanont P, Chaiyasamut T, Vongsavan K, Bhattarai BP, Pairuchvej V, Kiattavorncharoen S, Wongsirichat N. Comparative efficiency of the preoperative pterygomandibular space injection of two doses of dexamethasone in mandibular third molar surgery. J Dent Anesth Pain Med. 2021 Feb;21(1):29-39. doi: 10.17245/jdapm.2021.21.1.29. Epub 2021 Jan 29. Erratum In: J Dent Anesth Pain Med. 2023 Feb;23(1):55. doi: 10.17245/jdapm.2023.23.1.55. PubMed 33585682 ↗
  • Warraich R, Faisal M, Rana M, Shaheen A, Gellrich NC, Rana M. Evaluation of postoperative discomfort following third molar surgery using submucosal dexamethasone - a randomized observer blind prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jul;116(1):16-22. doi: 10.1016/j.oooo.2012.12.007. Epub 2013 Feb 28. PubMed 23453611 ↗
  • Mojsa IM, Pokrowiecki R, Lipczynski K, Czerwonka D, Szczeklik K, Zaleska M. Effect of submucosal dexamethasone injection on postoperative pain, oedema, and trismus following mandibular third molar surgery: a prospective, randomized, double-blind clinical trial. Int J Oral Maxillofac Surg. 2017 Apr;46(4):524-530. doi: 10.1016/j.ijom.2016.11.006. Epub 2016 Dec 21. PubMed 28012633 ↗
  • Parhizkar P, Schmidlin PR, Bornstein MM, Fakheran O. Can adjunctive corticosteroid therapy improve patient-centered outcomes following third molar surgery? A systematic review. Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27(5):e410-e418. doi: 10.4317/medoral.25177. PubMed 35975802 ↗
  • Moraschini V, Hidalgo R, Porto Barboza Ed. Effect of submucosal injection of dexamethasone after third molar surgery: a meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg. 2016 Feb;45(2):232-40. doi: 10.1016/j.ijom.2015.09.008. Epub 2015 Oct 14. PubMed 26458538 ↗
  • Kiencalo A, Jamka-Kasprzyk M, Panas M, Wyszynska-Pawelec G. Analysis of complications after the removal of 339 third molars. Dent Med Probl. 2021 Jan-Mar;58(1):75-80. doi: 10.17219/dmp/127028. PubMed 33789003 ↗
  • Aljafar A, Alibrahim H, Alahmed A, AbuAli A, Nazir M, Alakel A, Almas K. Reasons for Permanent Teeth Extractions and Related Factors among Adult Patients in the Eastern Province of Saudi Arabia. ScientificWorldJournal. 2021 Feb 22;2021:5534455. doi: 10.1155/2021/5534455. eCollection 2021. PubMed 33688305 ↗

Individual participant data

Plan to share: No — All data gathered and agreed upon by the institution's research ethical committee throughout the conduction of the clinical trial will be shared at the time of publication.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06953440
Lead sponsor
King Abdulaziz University
Responsible party
Lojain Bassyoni (Oral and Maxillofacial Surgery Consultant and Assistant Professor, King Abdulaziz University) — Principal investigator
First posted
May 1, 2025
Start date
Feb 1, 2024
Primary completion
May 30, 2025 (estimated)
Completion
Jun 30, 2025 (estimated)
Last update
May 1, 2025

Study contacts

Lojain Bassyoni, BDS, MSc, FRCDC
Contact
lbassyoni@kau.edu.sa
00966504623553
Razan Baabdullah, BDS, MSc, FRCDC
Contact
rmsbaabdullah@kau.edu.sa
00966555015167

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Dexamethasone phosphate

Start the discussion